Viewing Study NCT06344468



Ignite Creation Date: 2024-05-06 @ 8:21 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06344468
Status: COMPLETED
Last Update Posted: 2024-04-03
First Post: 2024-03-07

Brief Title: The Effect of Early Mobilization on Sleep Physiological Parameters and Length of Stay in ICU
Sponsor: Istanbul University - Cerrahpasa IUC
Organization: Istanbul University - Cerrahpasa IUC

Study Overview

Official Title: The Effect of Early Mobilization on Sleep Physiological Parameters and Length of Stay in ICU A Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this is randomized controlled study to examine the effect of early mobilization on sleep physiological parameters and length of stay in the intensive care unit ICU

The hypothesis are

Hypothesis I Early mobilization positively affects the sleep quality of patients

Hypothesis II Early mobilization positively affects the physiological parameters of patients respiratory rate heart rate blood pressure body temperature pain

Hypothesis III Early mobilization shortens the length of stay of patients in the intensive care unit ICU

Early mobilization will begin in the experimental group after sedation is discontinued within the first 12 hours and its effects disappear In early mobilization in the evaluation of in-bed mobilization physiological parameters respiratory rate sPO 2 heart rate blood pressure body temperature pain will be evaluated and recorded in the supine semi-fowler position In out-of-bed mobilization the patients physiological parameters respiratory rate sPO 2 heart rate blood pressure body temperature pain will be determined and recorded before mobilization and when the head is in a 45 upward position Surgical wounds and dressing areas if any are protected drains are identified care is taken not to remove equipment such as urinary catheters or nasogastric tubes when the patient is seated on the edge of the bed with the help of a nurse when heshe is stood up next to the bed with the support of the nurse when heshe is made to sit in a chair next to the bed and when heshe is in a chair While sitting 1st minute 5th minute 10th minute respiratory rate sPO2 heart rate blood pressure body temperature values and pain levels will be recorded and these data will be evaluated on their own During mobilization if the patient develops chest pain arrhythmia hypertension systolic pressure160 mmHg or hypotension systolic pressure90 mmHg tachypnea or hypoxia a break will be taken and the physician will be consulted The same procedures will be repeated during the mobilization of the patient in the first 24-36 hours and the necessary records will be made by the researcher

Control Group

After admission to the Cardiovascular Surgery ICU the type purpose and implementation process of the study will be explained to the patients and a routinestandard postoperative mobilization procedure will be applied to the patients in the control group Accordingly patients will be mobilized in the first 24 hours after surgery and in the evaluation of in-bed mobilization their physiological parameters respiratory rate sPO 2 heart rate blood pressure body temperature pain will be evaluated and recorded in the supine semi-fowler position In out-of-bed mobilization the patients physiological parameters respiratory rate sPO 2 heart rate blood pressure body temperature pain will be determined and recorded before mobilization and when the head is in a 45 upward position Again arterial blood gas monitoring of the patients in the control group will be performed at maximum 4-hour intervals and respiratory parameters will be frequently evaluated and recorded
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None